Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ...
{{id}} {{{paragraph}}}
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use SEROQUEL safely and effectively. See full PRESCRIBING INFORMATION for SEROQUEL.
titration and careful monitoring during the initial dosing period in the . elderly (2.3, 8.5) • Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be needed (2.4, 8.7, 12.3) DOSAGE FORMS AND STRENGTHS -----
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}